SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-000396
Filing Date
2023-01-09
Accepted
2023-01-09 06:05:57
Documents
14
Period of Report
2023-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvro-20230109.htm   iXBRL 8-K 58860
2 EX-99.1 nvro-ex99_1.htm EX-99.1 41900
3 GRAPHIC img258922048_0.jpg GRAPHIC 3333
  Complete submission text file 0000950170-23-000396.txt   231129

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvro-20230109_lab.xml EX-101.LAB 13474
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvro-20230109.xsd EX-101.SCH 2460
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvro-20230109_pre.xml EX-101.PRE 9894
8 EXTRACTED XBRL INSTANCE DOCUMENT nvro-20230109_htm.xml XML 4731
Mailing Address 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065 650-251-0005
NEVRO CORP (Filer) CIK: 0001444380 (see all company filings)

IRS No.: 562568057 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36715 | Film No.: 23516410
SIC: 3841 Surgical & Medical Instruments & Apparatus